Speech Disorders: Clinical Trials

13 trials for Speech Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 13
Phase 23Completed 3

Follow Speech Disorders: new trials by email Literature Review of Speech Disorders trials Research Report on Speech Disorders

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
QBS10072S - Astrocytoma, Brain Cancer
Phase 1CompletedQuadriga Biosciences, Inc.152020-07-202023-01-18
Proof-of-concept Study of LUNA Intervention in Aphasia
LUNA - Aphasia, Stroke
Phase 1CompletedCity, University of London282020-06-142023-05-06
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
Bioactive Factors, Produced by M2 Type Macrophages (M2-BFs). - Language Delay, Language; Developmental Disorder, Expressive
Phase 1 / Phase 2CompletedRussian Academy of Medical Sciences142020-02-012022-05-02
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia
F-18 AV 1451 - Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia
Phase 1CompletedMayo Clinic812016-07-012025-11-21
Brief Behavioral Treatment for Anxiety in Young Children
Parent-Led Exposure Therapy, Treatment As Usual - Obsessive-compulsive Disorder, Social Phobia
Phase 1 / Phase 2CompletedUniversity of South Florida582014-01-012016-10-06
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
C-11 PiB - Atypical Alzheimers Disease, Logopenic Variant of Primary Progressive Aphasia (LPA)
Phase 1CompletedMayo Clinic272012-11-012015-12-21
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Transcranial Direct Current Stimulation - Cathodal stimulation, Transcranial Direct Current Stimulation - Anodal stimulation, Transcranial Direct Current Stimulation - Sham stimulation - Nonfluent Aphasia, Stroke
Phase 1CompletedShirley Ryan AbilityLab122010-03-012017-05-15
PiB PET Scanning in Speech and Language Based Dementias
C-11 PiB, F-18 FDG - PPA, Primary Progressive Aphasia
Phase 1CompletedMayo Clinic1682010-03-012015-12-22
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
davunetide (AL-108, NAP), Placebo nasal spray - Predicted Tauopathies, Including, Progressive Supranuclear Palsy
Phase 1CompletedUniversity of California, San Francisco122010-01-012019-04-05
Treating Intention In Aphasia: Neuroplastic Substrates
Word-finding with intention component, Word-finding with no intention component - Aphasia, Cerebrovascular Accident
Phase 1 / Phase 2CompletedUniversity of Florida142007-03-012012-05-03
Improve Speech Using an In-the-ear Device in Parkinson's Disease
SpeechEasy Model ITC - Parkinson's Disease, Dysarthria
Phase 1CompletedRush University Medical Center402006-06-012013-01-18
Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.
Cortical Electrical Stimulation - Stroke, Broca's Aphasia
Phase 1CompletedNorthstar Neuroscience82004-12-012007-09-21
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Transcranial Magnetic Stimulation, Repetitive - Aphasia, Cerebrovascular Stroke
Phase 1CompletedBoston University632002-07-012017-01-31

Narrower conditions

Aphasia (6)  ·  Stroke (5)  ·  Aphasia, Broca (3)  ·  Language (3)  ·  Aphasia, Primary Progressive (2)  ·  Frontotemporal Dementia (2)  ·  Ischemic Stroke (2)  ·  Primary Progressive Nonfluent Aphasia (2)  ·  Speech (2)  ·  Anorexia (1)  ·  Anxiety Disorders (1)  ·  Anxiety, Separation (1)  ·  Apraxias (1)  ·  Astrocytoma (1)

Broader conditions

Communication Disorders (13)  ·  Nervous System Diseases (13)  ·  Neurobehavioral Manifestations (13)  ·  Neurologic Manifestations (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (13)  ·  Language Disorders (12)  ·  Brain Diseases (10)  ·  Central Nervous System Diseases (10)  ·  Behavior (5)  ·  Cardiovascular Diseases (5)  ·  Cerebrovascular Disorders (5)  ·  Communication (5)  ·  Mental Disorders (5)

Interventions

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (2)  ·  Therapeutics (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Transcranial Magnetic Stimulation (1)  ·  davunetide (1)

Sponsors

Mayo Clinic (3)  ·  Boston University (1)  ·  City, University of London (1)  ·  Northstar Neuroscience (1)  ·  Quadriga Biosciences, Inc. (1)  ·  Rush University Medical Center (1)  ·  Russian Academy of Medical Sciences (1)  ·  Shirley Ryan AbilityLab (1)  ·  University of California, San Francisco (1)  ·  University of Florida (1)  ·  University of South Florida (1)

Countries

United States (10)  ·  Australia (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Adam L. Boxer, M.D., Ph.D. (1)  ·  Alexander A Ostanin, MD, PhD (1)  ·  Alvaro Pascual-Leone, M.D., Ph.D. (1)  ·  Bruce Crosson, PhD (1)  ·  Elena R Chernykh, MD, PhD (1)  ·  Emily Wang, PHD (1)  ·  H B Coslett, M.D. (1)  ·  Jennifer Whitwell, PhD (1)  ·  Keith A Josephs, M.D. (1)  ·  Keith A Josephs, M.D. MST, MSc (1)  ·  Leo Verhagen, MD, PHD (1)  ·  Leora R Cherney, PhD (1)  ·  Margaret A Naeser, Ph.D. (1)

Results publications

PMID 15118944, PMID 15766771, PMID 16006338, PMID 19695692, PMID 20159655, PMID 20299861, PMID 21794852, PMID 21864891, PMID 23280015, PMID 26704258, PMID 29256908, PMID 38875279

NIH funding

R01DC005672 (1), R01DC007387 (1), R21DC009876 (1), R21NS094684 (1)